Path Biotech
Organisation
People
Sources: reporter.nih.gov
Grants and prizes
R41, Novel Combinations of Natural Product Compounds for Treatment of Alzheimer Disease and Related Dementias, R41AG080957, US$500k, 2023–2024, 13 Mar 2023
Sources: reporter.nih.gov
Named in competing interests
Cerebrovascular p16INK4A expression induces cerebral small vessel disease-related phenotypes
Consulting or advice, Board or leadership role, 12 Aug 2025
Sources: pubmed.ncbi.nlm.nih.gov